Rebound of residual plasma viremia after initial decrease following addition of intravenous immunoglobulin to effective antiretroviral treatment of HIV

BACKGROUND: High dosage of intravenous immunoglobulin (IVIG) has been observed as a possible activator of HIV gene expression in latently infected resting CD4(+ )T-cells, leading to a substantial decrease in both the reservoir and the residual plasma viremia when added to effective ART. IVIG treatme...

Descripción completa

Detalles Bibliográficos
Autores principales: Mellberg, Tomas, Gonzalez, Veronica D, Lindkvist, Annica, Edén, Arvid, Sönnerborg, Anders, Sandberg, Johan K, Svennerholm, Bo, Gisslén, Magnus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3136401/
https://www.ncbi.nlm.nih.gov/pubmed/21708049
http://dx.doi.org/10.1186/1742-6405-8-21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3136401/
https://www.ncbi.nlm.nih.gov/pubmed/21708049
http://dx.doi.org/10.1186/1742-6405-8-21

Ejemplares similares